Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03920839 |
Title | INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105) |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Incyte Corporation |
Indications | |
Therapies |
Carboplatin + Paclitaxel + Retifanlimab Cisplatin + Gemcitabine + Retifanlimab |
Age Groups: | adult | senior |
Covered Countries |
Facility | Status | City | State | Zip | Country | Details |
---|